What is Bunge Global SA's earnings per share (EPS)?

Bunge Global SA (BG) reported diluted earnings per share of $4.91 for fiscal year 2025. This represents a -38.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Bunge Global SA Financials

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Bunge Global SA (BG) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 50/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Growth

Bunge Global SA's revenue surged 32.4% year-over-year to $70.3B, reflecting rapid business expansion. This strong growth earns a score of 87/100.

Leverage

Bunge Global SA carries a low D/E ratio of 0.56, meaning only $0.56 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 91/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Bunge Global SA's current ratio of 1.61 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 28/100, which could limit financial flexibility.

Cash Flow

While Bunge Global SA generated $844.0M in operating cash flow, capex of $1.7B consumed most of it, leaving -$879.0M in free cash flow. This results in a low score of 22/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Bunge Global SA generates a 5.1% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 23/100. This is down from 11.5% the prior year.

Piotroski F-Score Weak

3/9

Bunge Global SA passes 3 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.03x

For every $1 of reported earnings, Bunge Global SA generates $1.03 in operating cash flow ($844.0M OCF vs $816.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$70.3B

YoY+32.4%

Bunge Global SA generated $70.3B in revenue in fiscal year 2025. This represents an increase of 32.4% from the prior year.

EBITDA

N/A

Net Income

$816.0M

YoY-28.2%

Bunge Global SA reported $816.0M in net income in fiscal year 2025. This represents a decrease of 28.2% from the prior year.

EPS (Diluted)

$4.91

YoY-38.5%

Bunge Global SA earned $4.91 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 38.5% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$879.0M

YoY-267.7%

Bunge Global SA generated -$879.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 267.7% from the prior year.

Cash & Debt

$1.1B

YoY-65.7%

Bunge Global SA held $1.1B in cash against $8.8B in long-term debt as of fiscal year 2025.

Dividends Per Share

$2.80

YoY+2.9%

Bunge Global SA paid $2.80 per share in dividends in fiscal year 2025. This represents an increase of 2.9% from the prior year.

Shares Outstanding

N/A

Margins & Returns

Gross Margin

4.9%

YoY-1.5pp

Bunge Global SA's gross margin was 4.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.5 percentage points from the prior year.

Operating Margin

N/A

Net Margin

1.2%

YoY-1.0pp

Bunge Global SA's net profit margin was 1.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.0 percentage points from the prior year.

Return on Equity

5.1%

YoY-6.3pp

Bunge Global SA's ROE was 5.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 6.3 percentage points from the prior year.

Capital Allocation

R&D Spending

$28.0M

YoY-6.7%

Bunge Global SA invested $28.0M in research and development in fiscal year 2025. This represents a decrease of 6.7% from the prior year.

Share Buybacks

$551.0M

YoY-49.9%

Bunge Global SA spent $551.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 49.9% from the prior year.

Capital Expenditures

$1.7B

YoY+25.2%

Bunge Global SA invested $1.7B in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 25.2% from the prior year.

BG Income Statement

Metric	FY25	FY24	FY23	FY22	FY21
Revenue	$70.3B+32.4%	$53.1B-10.8%	$59.5B-11.4%	$67.2B+13.7%	$59.2B
Cost of Revenue	$66.9B+34.6%	$49.7B-9.1%	$54.7B-13.9%	$63.5B+13.9%	$55.8B
Gross Profit	$3.4B+0.5%	$3.4B-30.0%	$4.8B+31.6%	$3.7B+9.5%	$3.4B
R&D Expenses	$28.0M-6.7%	$30.0M-14.3%	$35.0M+6.1%	$33.0M0.0%	$33.0M
SG&A Expenses	$2.1B+19.0%	$1.8B+3.6%	$1.7B+25.3%	$1.4B+10.9%	$1.2B
Operating Income	N/A	N/A	N/A	N/A	N/A
Interest Expense	$628.0M+33.3%	$471.0M-8.7%	$516.0M+28.0%	$403.0M+65.8%	$243.0M
Income Tax	$288.0M-14.3%	$336.0M-52.9%	$714.0M+84.0%	$388.0M-2.5%	$398.0M
Net Income	$816.0M-28.2%	$1.1B-49.3%	$2.2B+39.3%	$1.6B-22.5%	$2.1B
EPS (Diluted)	$4.91-38.5%	$7.99-46.3%	$14.87+41.5%	$10.51-22.9%	$13.64

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$23.8B+7.3%	$22.2B+73.5%	$12.8B+9.7%	$11.6B-14.0%	$13.5B+4.9%	$12.9B-2.5%	$13.2B-1.3%	$13.4B
Cost of Revenue	N/A	$21.1B+75.3%	$12.0B+8.9%	$11.0B	N/A	$12.1B-3.5%	$12.6B+0.3%	$12.5B
Gross Profit	$1.0B-4.9%	$1.1B+44.0%	$738.0M+23.6%	$597.0M-44.8%	$1.1B+40.0%	$772.0M+16.3%	$664.0M-24.2%	$876.0M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	$678.0M+62.2%	$418.0M+10.0%	$380.0M	N/A	$437.0M-2.7%	$449.0M+2.3%	$439.0M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	$202.0M+90.6%	$106.0M+1.9%	$104.0M	N/A	$127.0M+3.3%	$123.0M+13.9%	$108.0M
Income Tax	N/A	$86.0M-30.6%	$124.0M+55.0%	$80.0M	N/A	$89.0M+196.7%	$30.0M-74.4%	$117.0M
Net Income	$95.0M-42.8%	$166.0M-53.1%	$354.0M+76.1%	$201.0M-66.6%	$602.0M+172.4%	$221.0M+215.7%	$70.0M-71.3%	$244.0M
EPS (Diluted)	$0.49-41.7%	$0.84-67.8%	$2.61+76.4%	$1.48-66.1%	$4.36+179.5%	$1.56+225.0%	$0.48-71.4%	$1.68

BG Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21
Total Assets	$44.5B+78.8%	$24.9B-1.9%	$25.4B+3.2%	$24.6B+3.2%	$23.8B
Current Assets	$24.4B+52.8%	$16.0B-2.4%	$16.4B-2.4%	$16.8B	N/A
Cash & Equivalents	$1.1B-65.7%	$3.3B+27.2%	$2.6B+135.7%	$1.1B+22.4%	$902.0M
Inventory	$13.2B+103.3%	$6.5B-8.6%	$7.1B-15.5%	$8.4B	N/A
Accounts Receivable	$3.9B+80.2%	$2.1B-17.1%	$2.6B-8.4%	$2.8B	N/A
Goodwill	$3.1B+593.4%	$453.0M-7.4%	$489.0M+4.0%	$470.0M	N/A
Total Liabilities	$28.6B+91.0%	$15.0B+3.2%	$14.5B-5.4%	$15.4B-4.0%	$16.0B
Current Liabilities	$15.1B+103.5%	$7.4B-3.3%	$7.7B-19.9%	$9.6B	N/A
Long-Term Debt	$8.8B+88.1%	$4.7B+15.0%	$4.1B+25.2%	$3.3B	N/A
Total Equity	$15.9B+60.4%	$9.9B-8.6%	$10.9B+17.6%	$9.2B+17.9%	$7.8B
Retained Earnings	$13.2B+2.4%	$12.8B+6.3%	$12.1B+18.1%	$10.2B	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$44.5B-3.8%	$46.3B+48.6%	$31.2B+16.9%	$26.7B+7.1%	$24.9B-1.5%	$25.3B+3.4%	$24.4B-5.4%	$25.8B
Current Assets	$24.4B-8.7%	$26.7B+24.6%	$21.4B+23.4%	$17.4B+8.9%	$16.0B+0.2%	$15.9B+3.0%	$15.5B-7.7%	$16.7B
Cash & Equivalents	$1.1B-13.7%	$1.3B-80.6%	$6.8B+109.2%	$3.2B-2.0%	$3.3B+16.7%	$2.8B+144.3%	$1.2B-60.5%	$2.9B
Inventory	$13.2B-0.9%	$13.3B+66.1%	$8.0B+2.5%	$7.8B+20.4%	$6.5B-13.0%	$7.5B-7.3%	$8.1B+7.4%	$7.5B
Accounts Receivable	$3.9B+10.8%	$3.5B+54.7%	$2.3B-3.3%	$2.3B+8.7%	$2.1B+2.3%	$2.1B-7.8%	$2.3B-0.4%	$2.3B
Goodwill	$3.1B+13.4%	$2.8B+502.0%	$460.0M-0.6%	$463.0M+2.2%	$453.0M-6.0%	$482.0M+3.4%	$466.0M-2.9%	$480.0M
Total Liabilities	$28.6B-6.2%	$30.5B+50.6%	$20.3B+26.0%	$16.1B+7.3%	$15.0B-1.0%	$15.1B+4.9%	$14.4B-5.5%	$15.3B
Current Liabilities	$15.1B-6.0%	$16.1B+55.0%	$10.4B+21.7%	$8.5B+14.8%	$7.4B-3.3%	$7.7B+1.1%	$7.6B-9.8%	$8.4B
Long-Term Debt	$8.8B-10.0%	$9.8B+39.3%	$7.0B+49.4%	$4.7B+0.4%	$4.7B-1.7%	$4.8B+16.9%	$4.1B+0.2%	$4.1B
Total Equity	$15.9B+0.9%	$15.8B+44.9%	$10.9B+2.9%	$10.6B+6.7%	$9.9B-2.2%	$10.1B+1.3%	$10.0B-5.2%	$10.6B
Retained Earnings	$13.2B+0.8%	$13.1B+0.3%	$13.0B-0.2%	$13.0B+1.5%	$12.8B+5.0%	$12.2B+1.9%	$12.0B-2.6%	$12.3B

BG Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21
Operating Cash Flow	$844.0M-55.6%	$1.9B-42.6%	$3.3B+159.6%	-$5.5B-91.7%	-$2.9B
Capital Expenditures	$1.7B+25.2%	$1.4B+22.6%	$1.1B+102.2%	$555.0M+39.1%	$399.0M
Free Cash Flow	-$879.0M-267.7%	$524.0M-76.0%	$2.2B+135.8%	-$6.1B-85.4%	-$3.3B
Investing Cash Flow	-$5.2B-369.2%	-$1.1B-10.4%	-$1.0B-115.5%	$6.5B+27.1%	$5.1B
Financing Cash Flow	$2.2B+2576.7%	-$90.0M+89.5%	-$856.0M-11.3%	-$769.0M+52.9%	-$1.6B
Dividends Paid	$459.0M+21.4%	$378.0M-1.3%	$383.0M+9.7%	$349.0M+20.8%	$289.0M
Share Buybacks	$551.0M-49.9%	$1.1B+83.3%	$600.0M+200.0%	$200.0M+100.0%	$100.0M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$1.3B+57.7%	$854.0M+179.7%	-$1.1B-276.1%	-$285.0M-127.1%	$1.1B-20.6%	$1.3B+190.0%	-$1.5B-248.3%	$994.0M
Capital Expenditures	$538.0M+14.7%	$469.0M+15.5%	$406.0M+31.0%	$310.0M-36.6%	$489.0M+38.1%	$354.0M+19.2%	$297.0M+25.8%	$236.0M
Free Cash Flow	$809.0M+110.1%	$385.0M+126.0%	-$1.5B-148.4%	-$595.0M-205.5%	$564.0M-42.0%	$973.0M+154.9%	-$1.8B-333.6%	$758.0M
Investing Cash Flow	$297.0M+105.5%	-$5.4B-3146.1%	$178.0M+163.6%	-$280.0M-78.3%	-$157.0M+61.6%	-$409.0M-169.1%	-$152.0M+61.6%	-$396.0M
Financing Cash Flow	-$1.8B-95.4%	-$917.0M-120.6%	$4.4B+807.8%	$490.0M+205.2%	-$466.0M-161.0%	$764.0M+692.2%	-$129.0M+50.2%	-$259.0M
Dividends Paid	$135.0M-2.9%	$139.0M+47.9%	$94.0M+3.3%	$91.0M0.0%	$91.0M-5.2%	$96.0M0.0%	$96.0M+1.1%	$95.0M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

BG Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21
Gross Margin	4.9%-1.5pp	6.4%-1.8pp	8.1%+2.7pp	5.5%-0.2pp	5.7%
Operating Margin	N/A	N/A	N/A	N/A	N/A
Net Margin	1.2%-1.0pp	2.1%-1.6pp	3.8%+1.4pp	2.4%-1.1pp	3.5%
Return on Equity	5.1%-6.3pp	11.5%-9.2pp	20.7%+3.2pp	17.4%-9.1pp	26.6%
Return on Assets	1.8%-2.7pp	4.6%-4.3pp	8.8%+2.3pp	6.6%-2.2pp	8.7%
Current Ratio	1.61-0.5	2.15+0.0	2.13+0.4	1.75	N/A
Debt-to-Equity	0.56+0.1	0.47+0.1	0.38+0.0	0.35-1.7	2.04
FCF Margin	-1.3%-2.2pp	1.0%-2.7pp	3.7%+12.8pp	-9.1%-3.5pp	-5.6%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	4.3%-0.5pp	4.8%-1.0pp	5.8%+0.6pp	5.1%-2.8pp	8.0%+2.0pp	6.0%+1.0pp	5.0%-1.5pp	6.5%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	0.4%-0.3pp	0.8%-2.0pp	2.8%+1.0pp	1.7%-2.7pp	4.5%+2.7pp	1.7%+1.2pp	0.5%-1.3pp	1.8%
Return on Equity	0.6%-0.5pp	1.1%-2.2pp	3.3%+1.4pp	1.9%-4.2pp	6.1%+3.9pp	2.2%+1.5pp	0.7%-1.6pp	2.3%
Return on Assets	0.2%-0.1pp	0.4%-0.8pp	1.1%+0.4pp	0.8%-1.7pp	2.4%+1.6pp	0.9%+0.6pp	0.3%-0.7pp	0.9%
Current Ratio	1.61-0.0	1.66-0.4	2.07+0.0	2.04-0.1	2.15+0.1	2.07+0.0	2.03+0.0	1.99
Debt-to-Equity	0.56-0.1	0.62-0.0	0.65+0.2	0.45-0.0	0.470.0	0.47+0.1	0.41+0.0	0.39
FCF Margin	3.4%+1.7pp	1.7%+13.3pp	-11.6%-6.5pp	-5.1%-9.3pp	4.2%-3.4pp	7.5%+20.9pp	-13.4%-19.0pp	5.7%

Similar Companies

Tyson Foods TSN

$22.8B

Archer Daniels Midland Co ADM

$35.6B

Cal Maine Foods Inc CALM

$3.7B

Vital Farms, Inc. VITL

$564.0M

Clorox Co Del CLX

$12.2B

Frequently Asked Questions

What is Bunge Global SA's annual revenue?

Bunge Global SA (BG) reported $70.3B in total revenue for fiscal year 2025. This represents a 32.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Bunge Global SA's revenue growing?

Bunge Global SA (BG) revenue grew by 32.4% year-over-year, from $53.1B to $70.3B in fiscal year 2025.

Is Bunge Global SA profitable?

Yes, Bunge Global SA (BG) reported a net income of $816.0M in fiscal year 2025, with a net profit margin of 1.2%.

How much debt does Bunge Global SA have?

As of fiscal year 2025, Bunge Global SA (BG) had $1.1B in cash and equivalents against $8.8B in long-term debt.

What is Bunge Global SA's gross margin?

Bunge Global SA (BG) had a gross margin of 4.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Bunge Global SA's net profit margin?

Bunge Global SA (BG) had a net profit margin of 1.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Bunge Global SA pay dividends?

Yes, Bunge Global SA (BG) paid $2.80 per share in dividends during fiscal year 2025.

What is Bunge Global SA's return on equity (ROE)?

Bunge Global SA (BG) has a return on equity of 5.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Bunge Global SA's free cash flow?

Bunge Global SA (BG) generated -$879.0M in free cash flow during fiscal year 2025. This represents a -267.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Bunge Global SA's operating cash flow?

Bunge Global SA (BG) generated $844.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Bunge Global SA's total assets?

Bunge Global SA (BG) had $44.5B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Bunge Global SA's capital expenditures?

Bunge Global SA (BG) invested $1.7B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Bunge Global SA spend on research and development?

Bunge Global SA (BG) invested $28.0M in research and development during fiscal year 2025.

Does Bunge Global SA buy back shares?

Yes, Bunge Global SA (BG) spent $551.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

What is Bunge Global SA's current ratio?

Bunge Global SA (BG) had a current ratio of 1.61 as of fiscal year 2025, which is generally considered healthy.

What is Bunge Global SA's debt-to-equity ratio?

Bunge Global SA (BG) had a debt-to-equity ratio of 0.56 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Bunge Global SA's return on assets (ROA)?

Bunge Global SA (BG) had a return on assets of 1.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Bunge Global SA's Piotroski F-Score?

Bunge Global SA (BG) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Bunge Global SA's earnings high quality?

Bunge Global SA (BG) has an earnings quality ratio of 1.03x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Bunge Global SA?

Bunge Global SA (BG) scores 50 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.